Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ensysce Biosciences stock

Learn how to easily invest in Ensysce Biosciences stock.

Ensysce Biosciences Inc is a shell companies business based in the US. Ensysce Biosciences shares (LACQ) are listed on the PINK and all prices are listed in US Dollars.

How to buy shares in Ensysce Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LACQ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Ensysce Biosciences stock price (PINK: LACQ)

Use our graph to track the performance of LACQ stocks over time.

Ensysce Biosciences shares at a glance

Information last updated 2021-07-31.
Latest market close$13.85
52-week range$0.00 - $0.00
50-day moving average $13.97
200-day moving average $13.65
Wall St. target priceN/A
PE ratio 118.7705
Dividend yield N/A (0%)
Earnings per share (TTM) $0.12

Buy Ensysce Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Ensysce Biosciences price performance over time

Historical closes compared with the close of $13.85 from 2021-05-28

1 week (2022-09-16) N/A
1 month (2022-08-23) N/A
3 months (2022-06-23) N/A
6 months (2022-03-23) N/A
1 year (2021-09-23) N/A
2 years (2020-09-25) 32.54%
3 years (2019-09-27) 35.25%
5 years (2017-09-23) N/A

Is Ensysce Biosciences stock undervalued or overvalued?

Valuing Ensysce Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ensysce Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ensysce Biosciences's P/E ratio

Ensysce Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 119x. In other words, Ensysce Biosciences shares trade at around 119x recent earnings.

Ensysce Biosciences financials

Gross profit TTM $0
Return on assets TTM -1.25%
Return on equity TTM 23.4%
Profit margin 0%
Book value $0.30
Market capitalisation $90.2 million

TTM: trailing 12 months

Ensysce Biosciences share dividends

We're not expecting Ensysce Biosciences to pay a dividend over the next 12 months.

Ensysce Biosciences share price volatility

Over the last 12 months, Ensysce Biosciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Ensysce Biosciences's is -0.1134. This would suggest that Ensysce Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Ensysce Biosciences has bucked the trend.

Ensysce Biosciences overview

Ensysce Biosciences, Inc. operates as a biotechnology company that develops abuse-resistant drug technologies. It offers TAAP, a trypsin-activated abuse protection technology that prevents abuse through a two-step internal trypsin-activation process to meet the medical needs of patients living with chronic pain; and MPAR, a multi-pill abuse resistant technology that provides a layer of protection for overdose. The company was incorporated in 2003 and is based in La Jolla, California. .

Frequently asked questions

What percentage of Ensysce Biosciences is owned by insiders or institutions?
Currently 39.841% of Ensysce Biosciences shares are held by insiders and 56.672% by institutions.
When does the fiscal year end for Ensysce Biosciences?
Ensysce Biosciences's fiscal year ends in December.
Where is Ensysce Biosciences based?
Ensysce Biosciences's address is: 7946 IVANHOE AVENUE, La Jolla, CA, United States, 92037
What is Ensysce Biosciences's ISIN number?
Ensysce Biosciences's international securities identification number is: US2936021086
What is Ensysce Biosciences's CUSIP number?
Ensysce Biosciences's Committee on Uniform Securities Identification Procedures number is: 52539T107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site